Data Characteristics in This Category
Pharmacoeconomics knowledge data in pharmacovigilance primarily comes from post-market clinical study reports, Real World Evidence (RWE) databases, health insurance payment policy documents, national drug pricing and reimbursement guidelines, and the economic evaluation sections of Adverse Drug Reaction (ADR) monitoring reports. This data updates relatively infrequently, typically quarterly or annually, with new drug approvals, expanded indications, or health insurance policy adjustments. Document structures often include research reports, reviews, policy texts, or structured data tables. Fields and units are highly specialized, such as QALY (Quality-Adjusted Life Year), ICER (Incremental Cost-Effectiveness Ratio), DALY (Disability-Adjusted Life Year), various cost data (direct costs, indirect costs), and utility values. Units involve currencies like USD, EUR, CNY, and quality-of-life scores.
Constraints on Knowledge Base Retrieval and Recall
The low update frequency of pharmacoeconomics data means an initial bulk import of historical data is feasible when building the knowledge base. However, a regular review mechanism is necessary to capture policy or guideline updates. The diverse document structures require the knowledge base to support multiple file format parsers and effectively extract key economic indicators and conclusions from reports. For example, the system must identify and correctly parse PDF reports from pharmaceutical companies or government announcements, as well as specific values within tables. Specialized fields and units demand higher accuracy for retrieval and recall. Simple keyword matching may not capture the deep meaning of concepts like QALY or ICER, requiring semantic understanding. Contextual understanding of cost-benefit analysis is also crucial to avoid confusing data from different analytical backgrounds. The RAG mechanism must understand complex economic relationships embedded in sentences.
Configuration Settings
| Configuration Item | Suggested Value | Rationale |
|---|---|---|
Chunk size | 600–800 characters | Pharmacoeconomics report paragraphs are often long, containing complex arguments and data; maintaining complete context aids understanding. |
Chunk Overlap Length | 100–150 characters | Ensures contextual continuity between paragraphs, preventing critical information from being split at segment edges. |
Recall count | Top 5–8 entries | Answers to pharmacoeconomics questions often require multi-faceted data support; increasing recall quantity improves coverage. |
Similarity threshold | 0.75–0.85 | The domain has many specialized terms, and semantically similar but differently expressed situations are common; a higher threshold ensures recall relevance. |
Rerank result count | Top 3 entries | After re-ranking, the top few most relevant items often provide core economic conclusions. |
maxContext | 3000–4000 token | The complexity of pharmacoeconomics analysis requires a larger context window to accommodate recalled content. |
Three Common Pitfalls
- Retrieval results contain a large amount of irrelevant or outdated data, causing AI responses to drift off-topic. This typically occurs because the knowledge base lacks effective data cleansing and version management, or the recall similarity threshold is set too low.
- AI responses fail to accurately cite specific economic values or indicators from reports, providing only vague descriptions. This may be due to the document parser failing to correctly identify and extract structured data, or excessive segmentation leading to values being separated from their context.
- When a user asks about the economic evaluation of a specific drug, the AI responds with adverse reaction information for that drug. This indicates that the knowledge base's semantic understanding or retrieval model fails to effectively distinguish between the focus of pharmacoeconomics and traditional pharmacovigilance reports, or that the context of the retrieval request is mishandled.
How to Verify Configuration
- Select several representative pharmacoeconomics research reports. Ask questions about the core economic conclusions and key indicators within these reports to verify if the AI's answers accurately cite the original data.
- Simulate questions about specific drug health insurance payment policies or cost-benefit analyses. Check if the AI's responses align with the latest policy documents and can identify data sources.
- Conduct retrieval tests for specialized terms like QALY and ICER. Examine whether the recalled content includes definitions, calculation methods, and applications in specific cases for these terms to assess semantic understanding accuracy.
The values provided are common starting points and should be measured against specific samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.